Evidence map›Paper›PMID 34349153›Full record

ArticleScientific reports2021

HIV-1 molecular diversity in Brazil unveiled by 10 years of sampling by the national genotyping network.

Tiago Gräf, Gonzalo Bello, Paula Andrade, Ighor Arantes, João Marcos Pereira, Alexandre Bonfim Pinheiro da Silva, Rafael V Veiga, Diana Mariani, Lídia Theodoro Boullosa, Mônica B Arruda and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. HIV-1 integrase resistance in the context of antiretroviral therapy in paediatric patients ‒ Northeast Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tiago GräfFundação Oswaldo Cruz, Instituto Gonçalo Moniz, Rua Waldemar Falcão, 121, Salvador, 40296-710, Brazil. tiago.graf@fiocruz.br.
Gonzalo BelloLaboratório de AIDS e Imunologia Molecular, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Paula AndradeLaboratório de AIDS e Imunologia Molecular, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Ighor ArantesLaboratório de AIDS e Imunologia Molecular, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
João Marcos PereiraLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Alexandre Bonfim Pinheiro da SilvaLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Rafael V VeigaCenter of Data and Knowledge Integration for Health (CIDACS), Fundação Oswaldo Cruz, Instituto Gonçalo Moniz, Salvador, Brazil.
Diana MarianiLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Lídia Theodoro BoullosaLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Mônica B ArrudaLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
José Carlos Couto FernandezLaboratório de AIDS e Imunologia Molecular, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Ann M DennisDivision of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
David A RasmussenDepartment of Entomology and Plant Pathology, North Carolina State University, Raleigh, USA.
Amilcar TanuriLaboratório de Virologia Molecular, Departamento de Genética-IB, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Funding

Timely monitoring and response to HIV transmission networks for intensified preventionR01AI135970 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DENNIS, ANN · 2018 to 2022
$3.8M
NIAID NIH HHS R01 AI135970
6 · The paper itself

Abstract

HIV-1 has diversified into several subtypes and recombinant forms that are heterogeneously spread around the world. Understanding the distribution of viral variants and their temporal dynamics can help to design vaccines and monitor changes in viral transmission patterns. Brazil has one of the largest HIV-1 epidemics in the western-world and the molecular features of the virus circulating in the country are still not completely known. Over 50,000 partial HIV-1 genomes sampled between 2008 and 2017 by the Brazilian genotyping network (RENAGENO) were analyzed. Sequences were filtered by quality, duplicate sequences per patient were removed and subtyping was performed with online tools and molecular phylogeny. Association between patients' demographic data and subtypes were performed by calculating the relative risk in a multinomial analysis and trends in subtype prevalence were tested by Pearson correlation. HIV-1B was found to be the most prevalent subtype throughout the country except in the south, where HIV-1C prevails. An increasing trend in the proportion of HIV-1C and F1 was observed in several regions of the country, while HIV-1B tended to decrease. Men and highly educated individuals were more frequently infected by HIV-1B and non-B variants were more prevalent among women with lower education. Our results suggest that socio-demographic factors partially segregate HIV-1 diversity in Brazil while shaping viral transmission networks. Historical events could explain a preferential circulation of HIV-1B among men who have sex with men (MSM) and non-B variants among heterosexual individuals. In view of an increasing male/female ratio of AIDS cases in Brazil in the last 10-15 years, the decrease of HIV-1B prevalence is surprising and suggests a greater penetrance of non-B subtypes in MSM transmission chains.

Indexed as

PhylogenyAdolescentAdultBrazilFemaleGenotypeHIV-1HIV InfectionsHIV SeropositivityHumansLongitudinal StudiesMaleMiddle AgedYoung Adult

Identifiers

PMID34349153
PMCPMC8338987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.